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Recently, our partner journal Archives of Toxicology published a special issue addressing the 
key questions in nanotoxicology (Weiss and Diabaté, 2011). The number of commercially 
available nanomaterials is rapidly growing. Thus, one aspect of nanotoxicology is the unin-
tended exposure to nanomaterials. Pharmaceutical nanoproducts have been introduced for di-
agnostics, drug delivery or cancer treatment, and scientists in the field of toxicology are ex-
pected to identify and prevent side effects arising from these uses. To provide our readers 
with an overview of the latest topics in the field of nanotoxicology, we summarize the key 
messages of the recent special issue (Table 1). 
 
 
Table 1: Recent developments in nanotoxicology (from: Bolt et al., 2012)  
 
Key message Reference 
 
Quantum dots are frequently used to label cells. This article reviews 
the toxicity and biological behaviour of quantum dots and reports that 
the capping material rather than the care complex is relevant for toxic 
effects. 
Hoshino et al., 2011 
This article reviews possibilities and limitations of in vitro testing in 
nanotoxicology. 
Clift et al., 2011 (Review) 
 
Nanoparticles can activate various signalling pathways including 
ERK, p38, JNK as well as NFκB and Nrf-2. Interestingly, when these 
pathways are activated oxidative stress is observed. This article 
demonstrates that by far not all toxic effects of nanoparticles can be 
explained by oxidative stress. 
Marano et al., 2011 
Silver nanoparticles cause oxidative stress and induce bulky DNA 
adducts in a human lung cancer cell line. 
Foldbjerg et al., 2011 
 
Industrially manufactured nanoparticles can be radiolabelled by a cy-
clotron-based irradiation technique and are suitable for in vitro and in 
vivo tracing studies. 
Gibson et al., 2011 
High aspect carbon nanotubes (diameter 10-15 nm, length 10 µm) 
are more cytotoxic than low aspect nanotubes (diameter 10-15 nm, 
length 150 nm). However, both high and low aspect nanotubes were 
negative in the Ames test, in vitro chromosome aberration test and in 
vivo micronuclei test. 
Kim et al., 2011 
Depending on the type of functionalization, lead sulphide nanoparti-
cles show different degrees of toxicity to embryonic zebrafish.  This 
may be explained by the different extent of released soluble lead 
ions. 
Truong et al., 2011 
DNA strand breaks observed after incubation of colon carcinoma cells 
with platinum nanoparticles are caused by released platinum ions. 
Gehrke et al., 2011 
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Table 1 (cont.): Recent developments in nanotoxicology (from: Bolt et al., 2012)  
 
Key message Reference 
 
Silica nanoparticles accumulate in endosomes of HeLa cells. In con-
trast, they do not accumulate in nuclei or mitochondria. 
Al-Rawi et al., 2011 
 
The capacity of titanium dioxide nanoparticles to induce pulmonary 
irritation and inflammation in mice is low. 
Leppänen et al., 2011 
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